Skip to main navigation
Clene Inc. Clene Inc.
  • About Us
    • Leadership
    • Board of Directors
  • Science
    • Our Approach
    • About CNM-Au8®
  • Pipeline
  • EAP
    • EAP
    • ACT-EAP WITH CNM-Au8®
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • News
      • Events
    • Presentations
      • Investor Presentation
      • Scientific Posters & Presentations
      • Webinars
      • Publications
    • Corporate Governance
      • Executive Management
      • Board of Directors
      • Committee Composition
      • Governance Documents
    • Financial Information
      • SEC Filings
      • Annual Reports
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Analyst Coverage
    • Investor Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
  • Contact
Clene Inc. Clene Inc.
  • About Us
    • Leadership
    • Board of Directors
  • Science
    • Our Approach
    • About CNM-Au8®
  • Pipeline
  • EAP
    • EAP
    • ACT-EAP WITH CNM-Au8®
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • News
      • Events
    • Presentations
      • Investor Presentation
      • Scientific Posters & Presentations
      • Webinars
      • Publications
    • Corporate Governance
      • Executive Management
      • Board of Directors
      • Committee Composition
      • Governance Documents
    • Financial Information
      • SEC Filings
      • Annual Reports
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Analyst Coverage
    • Investor Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
  • Contact

Annual Reports

2025 AR
2025 Annual Report
2025 Annual Report to Stockholders 11.1 MB
2025 Proxy Statement 1.9 MB
2025 Additional Proxy Materials 501.1 KB
2025 Proxy Card 71.9 KB
2024 Annual Report
2024 Annual Report
2024 Annual Report to Stockholders 10.8 MB
2024 Proxy Statement 1.6 MB
2024 Additional Proxy Materials 524.9 KB
2024 Proxy Card 73.1 KB
2023 Annual Report
2023 Annual Report
2023 Annual Report to Stockholders 10.8 MB
2023 Proxy Statement 1.2 MB
2023 Additional Proxy Materials 572.2 KB
2023 Proxy Card 80.1 KB
2022 Annual Report
2022 Annual Report
2022 Annual Report to Stockholders 12.7 MB
2022 Proxy Statement 715.1 KB
2022 Additional Proxy Materials 320.9 KB
2022 Proxy Card 95.9 KB
2021 Annual Report
2021 Annual Report
2021 Annual Report to Stockholders 13.5 MB
2021 Proxy Statement 2.3 MB
2021 Additional Proxy Materials 689.9 KB
2021 Proxy Card 394.1 KB
2020 Annual Report
2020 Annual Report
2020 Annual Report to Stockholders 14.6 MB
2020 Proxy Statement 432 KB
2020 Additional Proxy Materials 28.7 KB
2020 Proxy Card 80.5 KB


1-801-676-9695
info@CleneNanomedicine.com
@CleneNano

Headquarters and Development

6550 South Millrock Drive, Suite G50
Salt Lake City, Utah 84121

Manufacturing, R&D

500 Principio Parkway West Suite 400
North East, Maryland 21901

Clene Nanomedicine, Inc. is a wholly owned subsidiary of Clene Inc. | © 2026 Clene Nanomedicine, Inc. - All rights reserved | PRIVACY POLICY | COOKIE POLICY | TERMS OF USE